This is a Validated Antibody Database (VAD) review about rhesus mac.. CD27, based on 59 published articles (read how Labome selects the articles), using CD27 antibody in all methods. It is aimed to help Labome visitors find the most suited CD27 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD27 synonym: TNFRSF7

BioLegend
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...
BioLegend CD27 antibody (BioLegend, 356412) was used in flow cytometry on human samples . Nature (2020) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig s1). Aging Cell (2020) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; 1:50; loading ...; fig s10b
BioLegend CD27 antibody (Biolegend, 302830) was used in flow cytometry on human samples at 1:50 (fig s10b). Science (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; 1:100; loading ...; fig 3d
BioLegend CD27 antibody (Biolegend, 302827) was used in flow cytometry on human samples at 1:100 (fig 3d). elife (2019) ncbi
mouse monoclonal (O323)
  • other; human; loading ...; fig 4b
BioLegend CD27 antibody (BioLegend, 302847) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig s3a
BioLegend CD27 antibody (BioLegend, 302816) was used in flow cytometry on human samples (fig s3a). Cell (2019) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; 1:100; loading ...; fig 1a
BioLegend CD27 antibody (Biolegend, 356404) was used in flow cytometry on human samples at 1:100 (fig 1a). elife (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 1a). BMC Res Notes (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 3a). Arthritis Res Ther (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD27 antibody (BioLegend, 302810) was used in flow cytometry on human samples (fig 1d). J Clin Invest (2019) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 3e
BioLegend CD27 antibody (Biolegend, 356406) was used in flow cytometry on human samples (fig 3e). Cell (2018) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig s4b
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig s4b). J Clin Invest (2018) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 9a
BioLegend CD27 antibody (Biolegend, 302828) was used in flow cytometry on human samples (fig 9a). J Virol (2018) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD27 antibody (BioLegend, M-T271) was used in flow cytometry on human samples (fig 2c). J Immunol (2018) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 1d). J Immunol (2018) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; 1:50; loading ...; fig 2a
BioLegend CD27 antibody (Biolegend, 356418) was used in flow cytometry on human samples at 1:50 (fig 2a). PLoS ONE (2017) ncbi
mouse monoclonal (M-T271)
  • immunohistochemistry - frozen section; human; loading ...; fig 3a
BioLegend CD27 antibody (BioLegend, 356401) was used in immunohistochemistry - frozen section on human samples (fig 3a). Leukemia (2018) ncbi
mouse monoclonal (O323)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CD27 antibody (BioLegend, O323) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 1d). Oncotarget (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 1b
In order to investigate the role of long-lived plasma cells in immunity and autoimmunity, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 1b). J Immunol (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 1b
BioLegend CD27 antibody (BioLegend, 302814) was used in flow cytometry on human samples (fig 1b). Scand J Immunol (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD27 antibody (Biolegend, 302808) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 2b
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 2b). Clin Immunol (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; 1:100; loading ...; fig s2
BioLegend CD27 antibody (BioLegend, 0323) was used in flow cytometry on human samples at 1:100 (fig s2). JCI Insight (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1b
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 1b). Sci Rep (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; rhesus macaque; loading ...; fig 3a
In order to establish the ability of the herpes simplex virus-1 VC2 vaccine to elicit immune responses in rhesus macaques, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on rhesus macaque samples (fig 3a). Vaccine (2017) ncbi
mouse monoclonal (O323)
  • blocking or activating experiments; human; 10 ug/ml; loading ...; fig 8a
In order to report the function of CD70-CD27 signaling in patients infected with Epstein-Barr virus, BioLegend CD27 antibody (BioLegend, O323) was used in blocking or activating experiments on human samples at 10 ug/ml (fig 8a). J Exp Med (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1e
In order to determine which cells express CD83, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; fig s4a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD27 antibody (Biolegend, M-T271) was used in flow cytometry on human samples (fig s4a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 2a
In order to identify and characterize a Nei endonuclease VIII-like 3 mutation in three siblings from a consanguineous family with autoimmunity, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 2a). J Clin Invest (2016) ncbi
mouse monoclonal (M-T271)
BioLegend CD27 antibody (Biolegend, 356404) was used . Nat Commun (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 3h
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 3h). Sci Rep (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 2b
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 2b). J Clin Invest (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 8
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, BioLegend CD27 antibody (BioLegend, 302830) was used in flow cytometry on human samples (fig 8). Nat Immunol (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; fig 1
BioLegend CD27 antibody (Biolegend, M-T271) was used in flow cytometry on human samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; African green monkey; loading ...; fig 2b
In order to discuss the use of flow cytometry to examine common marmosets, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on African green monkey samples (fig 2b). J Med Primatol (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 3
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 3). Am J Transplant (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
In order to evaluate the promotion of B cell activation and CXCR4 downregulation by CD161 and LLT1 expression in human germinal centers, BioLegend CD27 antibody (BioLegend, M-T271) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CD27 antibody (biolegend, O323) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; rhesus macaque; loading ...; fig 5c
In order to study the CD8+ non-cytolytic antiviral response in SIV infected rhesus macaques, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on rhesus macaque samples (fig 5c). PLoS ONE (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 1
In order to assess the CD4/CD8 ratio as a marker for CD4+ T cell dysfunction in chronic HIV infection, BioLegend CD27 antibody (Biolegend, clone O323) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 4
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 4). J Hematol Oncol (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 3c,3f
In order to look at patterns of S. Typhi-specific modulation of the homing potential of circulating Treg in patients with typhoid compared to healthy individuals, BioLegend CD27 antibody (biolegend, 302829) was used in flow cytometry on human samples (fig 3c,3f). PLoS Pathog (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
In order to determine if HIV elite controllers have exhausted T cells, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 1
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 1). Int Immunol (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 1
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 6
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 6). Am J Hum Genet (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 2
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 2). J Autoimmun (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; mouse; 1:100
In order to assess the role of CDH17 in the long-term survival of memory B cells in the bone marrow, BioLegend CD27 antibody (BioLegend, 302805) was used in flow cytometry on mouse samples at 1:100. PLoS ONE (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples . J Immunol Methods (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
In order to identify the role of GammaDelta T cells in acute HIV infection, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples . Ann Rheum Dis (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; rhesus macaque
In order to examine the effect of HMBPP-deficient Listeria mutant immunization, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on rhesus macaque samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; rhesus macaque
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
In order to examine human differentiated effector CD4(+) T cells that are defined by low levels of IL-2 and IL-7 receptors, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, BioLegend CD27 antibody (BioLegend, 0323) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
Bio-Rad
mouse monoclonal (LT27)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the role of long-lived plasma cells in immunity and autoimmunity, Bio-Rad CD27 antibody (AbD Serotec, LT27) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
Articles Reviewed
  1. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed publisher
  2. Callender L, Carroll E, Bober E, Akbar A, Solito E, Henson S. Mitochondrial mass governs the extent of human T cell senescence. Aging Cell. 2020;19:e13067 pubmed publisher
  3. Crank M, Ruckwardt T, Chen M, Morabito K, Phung E, Costner P, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019;365:505-509 pubmed publisher
  4. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed publisher
  5. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  6. Ahmed R, Omidian Z, Giwa A, Cornwell B, Majety N, Bell D, et al. A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen. Cell. 2019;177:1583-1599.e16 pubmed publisher
  7. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed publisher
  8. Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, et al. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro. BMC Res Notes. 2019;12:242 pubmed publisher
  9. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed publisher
  10. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  11. Bouafia A, Lofek S, Bruneau J, Chentout L, Lamrini H, Trinquand A, et al. Loss of ARHGEF1 causes a human primary antibody deficiency. J Clin Invest. 2019;129:1047-1060 pubmed publisher
  12. Jelcić I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, et al. Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis. Cell. 2018;175:85-100.e23 pubmed publisher
  13. Yeo L, Woodwyk A, Sood S, Lorenc A, Eichmann M, Pujol Autonell I, et al. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes. J Clin Invest. 2018;128:3460-3474 pubmed publisher
  14. Jegaskanda S, Mason R, Andrews S, Wheatley A, Zhang R, Reynoso G, et al. Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes. J Virol. 2018;92: pubmed publisher
  15. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed publisher
  16. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed publisher
  17. Svensson A, Patzi Churqui M, Schlüter K, Lind L, Eriksson K. Maturation-dependent expression of AIM2 in human B-cells. PLoS ONE. 2017;12:e0183268 pubmed publisher
  18. Klymenko T, Bloehdorn J, Bahlo J, Robrecht S, Akylzhanova G, Cox K, et al. Lamin B1 regulates somatic mutations and progression of B-cell malignancies. Leukemia. 2018;32:364-375 pubmed publisher
  19. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  20. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed publisher
  21. Arumugakani G, Stephenson S, Newton D, Rawstron A, Emery P, Doody G, et al. Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition. J Immunol. 2017;198:4618-4628 pubmed publisher
  22. Pérez Martínez C, Maravillas Montero J, Meza Herrera I, Vences Catalan F, Zlotnik A, Santos Argumedo L. Tspan33 is Expressed in Transitional and Memory B Cells, but is not Responsible for High ADAM10 Expression. Scand J Immunol. 2017;86:23-30 pubmed publisher
  23. Kaczmarek D, Kokordelis P, Kramer B, Glässner A, Wolter F, Goeser F, et al. Alterations of the NK cell pool in HIV/HCV co-infection. PLoS ONE. 2017;12:e0174465 pubmed publisher
  24. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed publisher
  25. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  26. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  27. Stanfield B, Pahar B, Chouljenko V, Veazey R, Kousoulas K. Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies. Vaccine. 2017;35:536-543 pubmed publisher
  28. Izawa K, Martin E, Soudais C, Bruneau J, Boutboul D, Rodriguez R, et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J Exp Med. 2017;214:73-89 pubmed publisher
  29. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  30. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  31. Massaad M, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, et al. Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. J Clin Invest. 2016;126:4219-4236 pubmed publisher
  32. Alivernini S, Kurowska Stolarska M, Tolusso B, Benvenuto R, Elmesmari A, Canestri S, et al. MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nat Commun. 2016;7:12970 pubmed publisher
  33. Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed publisher
  34. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed publisher
  35. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  36. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed publisher
  37. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  38. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  39. Llibre A, López Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, et al. LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol. 2016;196:2085-94 pubmed publisher
  40. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  41. Javed A, Leuchte N, Neumann B, Sopper S, Sauermann U. Noncytolytic CD8+ Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques. PLoS ONE. 2015;10:e0142086 pubmed publisher
  42. Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection. PLoS ONE. 2015;10:e0137635 pubmed publisher
  43. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed publisher
  44. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed publisher
  45. Pombo C, Wherry E, Gostick E, Price D, Betts M. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers. J Infect Dis. 2015;212:1376-86 pubmed publisher
  46. Inui M, Hirota S, Hirano K, Fujii H, Sugahara Tobinai A, Ishii T, et al. Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals. Int Immunol. 2015;27:345-55 pubmed publisher
  47. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed publisher
  48. Lewis M, Vyse S, Shields A, Boeltz S, Gordon P, Spector T, et al. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet. 2015;96:221-34 pubmed publisher
  49. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  50. Funakoshi S, Shimizu T, Numata O, Ato M, Melchers F, Ohnishi K. BILL-cadherin/cadherin-17 contributes to the survival of memory B cells. PLoS ONE. 2015;10:e0117566 pubmed publisher
  51. Woda M, Mathew A. Fluorescently labeled dengue viruses as probes to identify antigen-specific memory B cells by multiparametric flow cytometry. J Immunol Methods. 2015;416:167-77 pubmed publisher
  52. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed publisher
  53. Della Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015;74:2236-43 pubmed publisher
  54. Frencher J, Shen H, Yan L, Wilson J, Freitag N, Rizzo A, et al. HMBPP-deficient Listeria mutant immunization alters pulmonary/systemic responses, effector functions, and memory polarization of Vγ2Vδ2 T cells. J Leukoc Biol. 2014;96:957-67 pubmed publisher
  55. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  56. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  57. Cartwright E, McGary C, Cervasi B, Micci L, Lawson B, Elliott S, et al. Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections. J Immunol. 2014;192:4666-73 pubmed publisher
  58. Peguillet I, Milder M, Louis D, Vincent Salomon A, Dorval T, Piperno Neumann S, et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res. 2014;74:2204-16 pubmed publisher
  59. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher